Otsuka Holdings Co., Ltd. (OTSKY)

Market Cap	33.90B +20.5%
Revenue (ttm)	15.75B +6.0%
Net Income	2.32B +5.8%
EPS	4.37 +8.1%
Shares Out	n/a
PE Ratio	14.64
Forward PE	n/a
Dividend	0.93 (2.84%)
Ex-Dividend Date	Dec 29, 2025

Volume	29,514
Average Volume	35,593
Open	32.52
Previous Close	31.85
Day's Range	32.52 - 32.81
52-Week Range	21.64 - 34.93
Beta	-0.13
RSI	48.34
Earnings Date	Feb 13, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipme...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 34,388
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKY

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.

Financial numbers in JPY